4.1 Article

Modulation of immune cells and Th1/Th2 cytokines in insulin-treated type 2 diabetes mellitus.

期刊

AFRICAN HEALTH SCIENCES
卷 16, 期 3, 页码 712-724

出版社

MAKERERE UNIV, FAC MED
DOI: 10.4314/ahs.v16i3.11

关键词

Type 2 diabetes; Insulin; Immune cells; Th1/Th2 polarization

向作者/读者索取更多资源

Background: The role of the immune system in insulin resistance associated with type 2 diabetes has been suggested. Objectives: We assessed the profile of Th1/Th2 cytokines along with the frequencies of immune cells in insulin-treated type 2 diabetic patients (T2DP). Methods: 45 T2D patients and 43 age-matched healthy subjects were selected. Serum concentrations of T-helper type 1 (Th1) and Th2 cytokines and the frequencies of innate and adaptive immunity cells were assessed. Results: T2DP were hyperglycemic and showed high level of insulin, normal levels of triglycerides and total-cholesterol and without any change in HDL-cholesterol. Compared to healthy subjects, T2DP exhibited significant decreased frequencies of neutrophils, without any change in monocytes, eosinophils and natural killer cells. The percentages of total lymphocytes (CD3+) and CD8+-T-cells decreased whereas those of regulatory T-cells increased without any change in CD4+ T-cells in T2DP. Interestingly, the frequencies of effector CD4+-T and B-cells increased in T2DP. Serum concentrations of IL-2, IFN-gamma and IL-4 decreased while IL-10 significantly enhanced in T2DP, suggesting a differentiation of CD4+ T helper cells towards IL-10-producing-Teff-cells in these patients. Conclusion: Insulin-treated type 2 diabetes is associated with anti-inflammatory profile consistent with differentiation of CD4+-Th-cells towards IL-10-producing-Teff-cells, concomitant with increased frequencies of Treg and B-cells, and this may probably offer prevention against certain infections or autoimmune/inflammatory diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity

Magloire Pandoua Nekoua, Antoine Bertin, Famara Sane, Enagnon Kazali Alidjinou, Delphine Lobert, Jacques Trauet, Christine Hober, Ilka Engelmann, Kabirou Moutairou, Akadiri Yessoufou, Didier Hober

CELLULAR AND MOLECULAR LIFE SCIENCES (2020)

Article Immunology

Th2-Immune Polarizing and Anti-Inflammatory Properties of Insulin Are Not Effective in Type 2 Diabetic Pregnancy

Adnette Fagninou, Magloire Pandoua Nekoua, Darius Sossou, Kabirou Moutairou, Nadine Fievet, Akadiri Yessoufou

JOURNAL OF IMMUNOLOGY RESEARCH (2020)

Review Microbiology

Enteroviruses and Type 1 Diabetes Mellitus: An Overlooked Relationship in Some Regions

Abdulaziz Alhazmi, Famara Sane, Mouna Lazrek, Magloire Pandoua Nekoua, Francis Badia-Boungou, Ilka Engelmann, Enagnon Kazali Alidjinou, Didier Hober

MICROORGANISMS (2020)

Article Microbiology

Fluoxetine Can Inhibit SARS-CoV-2 In Vitro

Arthur Dechaumes, Magloire Pandoua Nekoua, Sandrine Belouzard, Famara Sane, Ilka Engelmann, Jean Dubuisson, Enagnon Kazali Alidjinou, Didier Hober

Summary: Fluoxetine (FLX) has shown potential to inhibit SARS-CoV-2 in vitro, suggesting its value in further research as a potential anti-viral treatment option against SARS-CoV-2 infections.

MICROORGANISMS (2021)

Review Microbiology

Effect of Coxsackievirus B4 Infection on the Thymus: Elucidating Its Role in the Pathogenesis of Type 1 Diabetes

Abdulaziz Alhazmi, Magloire Pandoua Nekoua, Helene Michaux, Famara Sane, Aymen Halouani, Ilka Engelmann, Enagnon Kazali Alidjinou, Henri Martens, Hela Jaidane, Vincent Geenen, Didier Hober

Summary: Viral infections, especially CVB4 infection, can disrupt thymic functions and may play a role in the pathogenesis of type 1 diabetes (T1D) by affecting thymic cells and functions.

MICROORGANISMS (2021)

Article Microbiology

Persistence of Coxsackievirus B4 in Pancreatic β Cells Disturbs Insulin Maturation, Pattern of Cellular Proteins, and DNA Methylation

Magloire Pandoua Nekoua, Antoine Bertin, Famara Sane, Jean-Pascal Gimeno, Isabelle Fournier, Michel Salzet, Ilka Engelmann, Enagnon Kazali Alidjinou, Didier Hober

Summary: Research shows that CV-B4 persistence in insulin-producing pancreatic beta cells leads to inhibition of pro-hormone convertase 2 expression, significant modification of cell protein patterns, and hypermethylation of cell DNA. These cellular changes caused by persistent CV-B4 infection can potentially contribute to the pathogenesis of type 1 diabetes.

MICROORGANISMS (2021)

Article Medicine, General & Internal

Low Serum Levels of Interferon Alpha in COVID-19 Patients Are Associated with Older Age

Enagnon Kazali Alidjinou, Mickael Hirabidian, Anthony Rabat, Mahdi Ouafi, Magloire Pandoua Nekoua, Famara Sane, Julien Poissy, Didier Hober

Summary: This study found a significant association between levels of IFN alpha and age in COVID-19 patients, which may explain the higher susceptibility of the elderly to severe COVID-19.

JOURNAL OF CLINICAL MEDICINE (2022)

Review Endocrinology & Metabolism

Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus

Magloire Pandoua Nekoua, Enagnon Kazali Alidjinou, Didier Hober

Summary: This review highlights the role of persistent enterovirus infections in triggering islet autoimmunity and type 1 diabetes mellitus (T1DM), and discusses the potential of vaccination or antiviral therapies in preventing T1DM onset.

NATURE REVIEWS ENDOCRINOLOGY (2022)

Article Microbiology

Fighting Enteroviral Infections to Prevent Type 1 Diabetes

Magloire Pandoua Nekoua, Ambroise Mercier, Abdulaziz Alhazmi, Famara Sane, Enagnon Kazali Alidjinou, Didier Hober

Summary: Enteroviruses, especially coxsackieviruses B, are believed to play a role in triggering or accelerating type 1 diabetes. Various antiviral drugs and vaccines have shown potential in preventing or reducing the risk of the disease.

MICROORGANISMS (2022)

Editorial Material Microbiology

Coxsackievirus Infection and Associated Diseases

Magloire Pandoua Nekoua, Didier Hober

MICROORGANISMS (2022)

Review Virology

Combating coxsackievirus B infections

Abdulaziz Alhazmi, Magloire Pandoua Nekoua, Ambroise Mercier, Ines Vergez, Famara Sane, Enagnon Kazali Alidjinou, Didier Hober

Summary: Coxsackieviruses B (CVB) is a common virus that can cause a wide range of diseases. Current approaches to control CVB infections include the development of drugs and vaccines, as well as alternative strategies. These methods have shown potential in preventing and treating CVB infections in vitro and in animal models.

REVIEWS IN MEDICAL VIROLOGY (2023)

Review Microbiology

Viruses and Endocrine Diseases

Magloire Pandoua Nekoua, Cyril Debuysschere, Ines Vergez, Corentin Morvan, Chaldam Jespere Mbani, Famara Sane, Enagnon Kazali Alidjinou, Didier Hober

Summary: Viral infections have long been associated with physiological and pathological changes in the endocrine system. The current pandemic of COVID-19 has revealed numerous endocrine complications, highlighting the need to better understand the impact of viral infections on the endocrine system. Several viruses can directly damage endocrine cells or indirectly disrupt the system through the activation of the host antiviral immune response, leading to inflammation or organ-specific autoimmunity. Furthermore, endocrine disorders can also impact susceptibility to viral infections due to the immunoregulatory functions of endocrine hormones.

MICROORGANISMS (2023)

Review Microbiology

The Fight against Poliovirus Is Not Over

Chaldam Jespere Mbani, Magloire Pandoua Nekoua, Donatien Moukassa, Didier Hober

Summary: Poliovirus (PV), classified within Enterovirus C species, causes both acute poliomyelitis and post-polio syndrome. Global Polio Eradication Initiative (GPEI) successfully eliminated two WPV serotypes, but WPV1 transmission remains in Afghanistan and Pakistan. Vaccine-derived poliovirus (VDPV) cases have been reported worldwide, leading to increased use of inactivated poliovirus vaccine (IPV) and development of new OPV formulations and alternative vaccines.

MICROORGANISMS (2023)

Review Microbiology

Markers of Epstein-Barr Virus Infection in Patients with Multiple Sclerosis

Cyril Debuysschere, Magloire Pandoua Nekoua, Didier Hober

Summary: Viral infections, particularly Epstein-Barr virus (EBV), have long been suspected to play a role in the development and progression of autoimmune diseases such as multiple sclerosis (MS), lupus, rheumatoid arthritis, Sjogren's syndrome, and type 1 diabetes. EBV has a complex lifecycle in infected B-cells, producing viral proteins and miRNAs. This review highlights the detection of EBV infection in MS patients, focusing on markers of latency and lytic phases. The presence of latency proteins, antibodies, and miRNAs in the central nervous system of MS patients suggests a link between EBV and MS.

MICROORGANISMS (2023)

Review Virology

Coxsackievirus B infection and pathogenesis of type 1 diabetes

Magloire Pandoua Nekoua, Ambroise Mercier, Ines Vergez, Corentin Morvan, Chaldam Jespere Mbani, Famara Sane, Delphine Lobert, Ilka Engelmann, Marie-Benedicte Romond, Enagnon Kazali Alidjinou, Didier Hober

Summary: Epidemiological and experimental studies suggest that enteroviruses, particularly coxsackieviruses B, may trigger or accelerate the onset of islet autoimmunity and the development of type 1 diabetes in genetically susceptible individuals. Several potential mechanisms have been proposed to explain the involvement of coxsackieviruses B in the pathogenesis of type 1 diabetes, including persistent infection in various cells and the resulting chronic inflammatory response and disruption of tolerance towards ss-cells. Vaccine or therapeutic strategies to control enterovirus infections show potential for the prevention or treatment of type 1 diabetes.

VIROLOGIE (2022)

暂无数据